| Authors: |
Fizazi K; Department of Medical Oncology, Centre Oscar Lambret, Lille, France; Department of Medical Oncology, University of Paris Saclay, Villejuif, France., Attard G; Research Department of Oncology, University College London, London, UK., Azad AA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Baciarello G; Department of Medical Oncology, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy., Beltran H; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, USA., Bjartell A; Department of Urology, Skåne University Hospital, Malmo, Sweden., Blanchard P; Department of Radiation Oncology, Gustave Roussy, Université Paris Saclay, INSERM U1018 Oncostat, Villejuif, France., Bossaert F; CerHom, Villejuif, France., Castro E; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Compérat E; Department of Pathology, Medical University of Vienna, Vienna, Austria., de Bono J; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK., Deschamps A; Europa Uomo, The European Prostate Cancer Coalition, Antwerp, Belgium., Efstathiou E; Knight Comprehensive Cancer Center, Oregon Health and Science University, Portland, USA., Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, Australia., Fanti S; Department of Nuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy., Fonteyne V; Department of Radiation Oncology, Ghent University, Ghent, Belgium., González-Del-Alba A; Medical Oncology Department, University Hospital Puerta de Hierro Majadahonda, Madrid, Spain., Gravis G; Department of Medical Oncology, Immunity and Cancer Team, Institut Paoli-Calmettes, INSERM, CNRS, CRCM, Aix Marseille University, Marseille, France., James ND; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., McDermott RS; Department of Medical Oncology, St Vincent's University Hospital & University College Dublin, Dublin, Ireland., Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Parker C; Urology Unit, The Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK., Renard-Penna RM; Department of Imagery, Hôpital Pitié Salpétrière, Sorbonne Université, Paris, France., Rubin MA; Department for Biomedical Research, University of Bern, Bern, Switzerland., Saad F; Department of Surgery and Urologic Oncology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Canada., Sweeney C; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia., Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Koc University Hospital, Istanbul, Turkey., Tombal B; Division of Urology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Tree AC; Division of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital, London, UK; Uro-Oncology Department, The Royal Marsden Hospital, Sutton, UK., Walz J; Department of Urology, Institut Paoli-Calmettes Cancer Center, Marseille, France., Zilli T; Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italian, Lugano, Switzerland., Gillessen S; Faculty of Biomedical Sciences, Università della Svizzera Italian, Lugano, Switzerland; Department of Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. |
